INNOVATION
Pioneering Innovation for Transformative Pharmaceutical Solutions
FOCUS
We are committed to introducing delivery systems that revolutionize widely prescribed pharmaceuticals to increase efficacy  and patient convenience .
				            APPROACH
 Guided by purpose,
 driven to innovate
					01
Delivery Systems
Revolutionizing the pharmaceutical market involves developing advanced delivery mechanisms for widely prescribed drugs, aiming to enhance their accessibility, efficacy and minimize side effects.
02
Administration
We are committed to simplifying medication routines for our customers by offering products that are easier to administer, aiming to improve adherence and outcomes.
03
Accessibility
We aim to expand our portfolio of medicines, increasing access across the United States and globally, providing advanced treatments to more patients.
Innovation
                    Our enteric coating technology  transforms the administration and delivery of existing drug families.                
            Raw material is extracted, concentrated and processed to powder
key component 1
Microencapsulation
A precision technique where active ingredients are encased in a polymer matrix, creating particles ranging from submicrons to millimeters
Ensures targeted delivery and enhanced drug stability
key component 2
Enteric Coating
Our specialized coating technology strategically delivers medication to the intestine, bypassing stomach degradation
Significantly reduces gastrointestinal side effects and enhances bioavailability
PRODUCTS
Altanine's proprietary coating can be used to create various delivery systems  for widely prescribed drugs
										                
Barrier free convenience
Chewable Tablets
A chewable, pleasant tasting alternative infused with medication offers a pill-free experience. It's a user-friendly option for those who prefer not to, or cannot take traditional pills.

Pain free administration
Coated Capsules
A specially coated capsule takes the place of a syringe, making injectable GLP-1 drugs such as Semaglutide easier to handle, administer, and store while increasing their efficacy and stability.

Comfort and immediacy
Aspiration Inhalers
An inhaler delivers medication directly to the lungs through inhalation, providing faster relief and fewer systemic side effects. This method improves both safety, efficacy and convenience.
GROWING PORTFOLIO OF PRODUCTS
                        Our future products, backed by a robust IP portfolio , are key to expanding market share and maintaining our competitive edge .                    
                    FDA 505(b)(2) Pathway An expedited approval process that allows for quicker development and approval of previously approved drugs. This significantly reduces the time associated with bringing new drug delivery methods, such as dry powder inhalers, and chewable tablets to market. By leveraging existing safety and efficacy data, Altanine can efficiently introduce treatments that enhance patient outcomes and address unmet medical needs.
Oncology & Chemotherapy drugs
Inhaled Insulin & Epinephrine
Cannabidiol (CBD)
ADVANCING PATIENT CARE
Our proprietary process seeks to increase drug efficacy 
																We aim to enhance patient comfort and convenience by improving the efficacy of medications.
- Proprietary enteric coating for targeted release
- Enhances bioavailability and improves absorption of medication
- Potential to lower the necessary dosages
- Potential to reduce gastrointestinal side effects
Stay current with news & product updates
* For information about our proprietary technology, intellectual property or products.
 
                        Thank You!
Your request has been received!
We will reach out to you shortly.









